TL;DR: Green Thumb Industries (OTC: GTBIF) reported Q3 2026 results Tuesday morning, posting revenue of $291.3 million — a beat of roughly $4 million above consensus — alongside adjusted EBITDA of $97.2 million at a 33.4% margin, reaffirming its standing as the MSO sector’s most disciplined operator. Free cash flow of $41.8 million marked the fourth consecutive quarter above $40 million, a milestone no other U.S. cannabis company has matched. With Illinois anchoring top-line growth and New Jersey accelerating, management issued conservative Q4 guidance of $285–295 million as it awaits potential Schedule III clarity heading into 2027.
Market Analysis: Q3 by the Numbers
Green Thumb’s Q3 2026 print delivered exactly what institutional holders had been underwriting: predictable cash generation and margin stability in an environment where several MSO peers have struggled with both. Revenue of $291.3 million represented 6.1% year-over-year growth from Q3 2025’s $274.6 million, driven by adult-use volume expansion in the company’s core Midwest and Mid-Atlantic markets rather than new-store chasing.
Illinois, GTI’s home market and highest-margin state, contributed an estimated $68 million in revenue — up modestly quarter-over-quarter as September saw stronger-than-expected consumer traffic heading into fall. New Jersey continued to be the growth story, with RISE stores generating approximately $22 million in Q3 revenue, up 18% sequentially as the competitive shakeout among undercapitalized operators tightened supply dynamics. Florida’s RISE network delivered roughly $31 million, building incremental share in a market historically dominated by Trulieve but increasingly contested by GTBIF’s expanded retail footprint.
Gross margin came in at 51.2%, steady against Q2’s 51.0%, a reflection of disciplined wholesale mix management. The adjusted EBITDA margin of 33.4% is the key figure for institutional models — it confirms that GTI can maintain peer-leading profitability without relying on aggressive revenue assumptions. GAAP EPS of $(0.03) reflects continued 280E tax drag; on an adjusted basis, the company printed $0.09 per share.
Management confirmed 94 RISE retail stores at quarter-end, with no net new openings in Q3. CEO Ben Kovler’s prepared remarks reiterated the company’s deliberate capital restraint posture: no store-count expansion commitments until the tax environment — specifically 280E resolution via Schedule III rescheduling — provides clearer unit economics visibility. CFO Anthony Georgiadis noted that 280E is costing Green Thumb approximately $31 million per quarter in excess federal tax obligations. A Schedule III final rule would add an estimated $28–32 million per quarter to GTBIF net income on a day-one basis, a figure that underpins much of the institutional bull case.
Regulatory and Market Context
The Q3 results land as the broader MSO sector navigates the final stretch of earnings season. Curaleaf’s Q3 analysis (published last Friday) confirmed that portfolio rationalization and 280E cost management are the prevailing themes across the peer group. Verano Holdings is expected to report Q3 results later this week, and with the October 20–24 earnings calendar now in focus, the Green Thumb print sets a constructive baseline for sector bulls who have been patient through a prolonged period of regulatory stasis.
On the regulatory front, DEA’s administrative law judge process for Schedule III continues to advance without a firm hearing date for Q4 2026. Industry participants broadly expect the first ALJ session in Q1 2027, with a final rule potentially arriving late 2027. For Green Thumb specifically, a 2027 rescheduling timeline is manageable given its $218 million cash balance and absence of near-term debt maturities — a balance sheet profile that eliminates the refinancing risk weighing on more leveraged competitors.
State-level tailwinds remain favorable in GTI’s core markets. New Jersey’s slower license issuance pace in 2026 has been broadly constructive for established operators, and Ohio’s adult-use ramp — where GTI’s RISE stores are participating — is tracking ahead of year-one consensus projections. Pennsylvania adult-use legalization, the sector’s most anticipated dormant catalyst, appears poised for 2027 legislative action rather than 2026, but GTI is already the state’s second-largest operator by dispensary count, positioning it for outsized benefit when the market opens.
Conclusion: The Benchmark Holds
Green Thumb Industries’ Q3 2026 results do precisely what the company’s institutional holders have come to expect: they eliminate downside surprises and validate the FCF-first thesis without providing ammunition for near-term exuberance. Q4 guidance of $285–295 million is deliberately conservative, reflecting both typical seasonal softness and management’s unwillingness to anchor to upside scenarios that depend on regulatory timelines outside its control.
For portfolio managers constructing cannabis sector exposure, GTBIF’s combination of FCF generation, balance sheet strength, and leverage to Schedule III resolution remains the sector’s most compelling risk-adjusted setup. Investors tracking GTBIF alongside Verano, Curaleaf, and the broader MSOS basket can monitor real-time price action and relative performance on the cannabis stock tracker. With Verano’s Q3 results expected this week and Trulieve’s print on deck, the earnings season isn’t finished — but GTI has set the bar.